Related references
Note: Only part of the references are listed.The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer
Stephanie L. Goff et al.
CLINICAL BREAST CANCER (2021)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes
Lei Wang et al.
EBIOMEDICINE (2020)
The Impact of Normalization Approaches to Automatically Detect Radiogenomic Phenotypes Characterizing Breast Cancer Receptors Status
Rossana Castaldo et al.
CANCERS (2020)
Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution's Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer
Angela Fischer Maranta et al.
BREAST (2020)
Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions (vol 10, 13203, 2020)
Manuela Gago-Dominguez et al.
SCIENTIFIC REPORTS (2020)
Prediagnostic Immune Cell Profiles and Breast Cancer
Jacob K. Kresovich et al.
JAMA NETWORK OPEN (2020)
Imbalances in cellular immunological parameters in blood predetermine tumor onset in a natural mouse model of breast cancer
Dmitry A. Aronov et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Purification of viable peripheral blood mononuclear cells for biobanking using a robotized liquid handling workstation
Luigi Coppola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Predictive and prognostic value of circulating blood lymphocyte subsets in metastatic breast cancer
Jian Yang et al.
CANCER MEDICINE (2019)
Ki-67 as a prognostic marker according to breast cancer molecular subtype
Nahed A. Soliman et al.
CANCER BIOLOGY & MEDICINE (2016)
The correlation between Ki-67 with other prognostic factors in breast cancer: A study in Iranian patients
Seyed-Hamid Madani et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2016)
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer
Yingbo Shao et al.
PLOS ONE (2015)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients
Mariarosaria Incoronato et al.
BMC CANCER (2014)
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
Sandra S. McAllister et al.
NATURE CELL BIOLOGY (2014)
13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)
Michael Untch et al.
BREAST CARE (2013)
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu-Trantien et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Brian F. Zamarron et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Lymphocytes in cancer development: Polarization towards pro-tumor immunity
Brian Ruffell et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Breast cancer prognostic classification in the molecular era: the role of histological grade
Emad A. Rakha et al.
BREAST CANCER RESEARCH (2010)
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert et al.
CANCER RESEARCH (2009)
Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes
B. -W. Park et al.
ANNALS OF ONCOLOGY (2008)
Additive logistic regression: A statistical view of boosting
J Friedman et al.
ANNALS OF STATISTICS (2000)
Share Paper
